Evidence map›Paper›PMID 34301916›Full record

Observational studyBlood cancer journal2021

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect

Hans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, Sundar Jagannath, Robert M Rifkin, Brian G M Durie, Mohit Narang, Howard R Terebelo, Kathleen Toomey, James W Hardin and 7 more

Abstract readLetterMulticenter StudyObservational Study
In one paragraph

Observational study in Blood cancer journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Observational
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Treatment of older adult or frail patients with multiple myeloma.Hematology. American Society of Hematology. Education Program · 2021
    Article
  11. Advances in Management for Older Adults With Hematologic Malignancies.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hans C LeeThe University of Texas MD Anderson Cancer Center, Houston, TX, USA. hclee@mdanderson.com.ORCID 0000-0001-8545-3292
Sikander AilawadhiMayo Clinic, Jacksonville, FL, USA.
Cristina J GasparettoDuke University Medical Center, Durham, NC, USA.
Sundar JagannathMount Sinai Hospital, New York, NY, USA.
Robert M RifkinRocky Mountain Cancer Centers US Oncology Research, Denver, CO, USA.
Brian G M DurieCedars-Sinai Medical Center, Los Angeles, CA, USA.
Mohit NarangMaryland Oncology Hematology, US Oncology Research, Columbia, MD, USA.
Howard R TerebeloProvidence Cancer Institute, Southfield, MI, USA.
Kathleen ToomeyThe Steeplechase Cancer Center, Somerville, NJ, USA.
James W HardinUniversity of South Carolina, Columbia, SC, USA.
Lynne WagnerWake Forest School of Medicine, Winston-Salem, NC, USA.
James L OmelMyeloma Research Advocate/Advisor, Grand Island, NE, USA.
Mazaher DhallaBristol Myers Squibb, Princeton, NJ, USA.
Liang LiuBristol Myers Squibb, Princeton, NJ, USA.
Prashant JoshiBristol Myers Squibb, Princeton, NJ, USA.
Rafat AbonourIndiana University, Indianapolis, IN, USA.
Connect® MM Registry

Funding

Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Rafael Fonseca · 2015 to 2026
$25.5M
NCI NIH HHS P50 CA186781
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overAge FactorsDisease ManagementFemaleHumansMaleMultiple MyelomaProgression-Free SurvivalRegistriesTreatment Outcome

Identifiers

PMID34301916
PMCPMC8302734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.